← FDA DRUG APPROVALS
FDA ANDA · ANDA085218
ACETAMINOPHEN AND CODEINE PHOSPHATE
Sponsor: WARNER CHILCOTT
APPLICATION
ANDA085218
TYPE
ANDA
ORIGINAL APPROVAL
1978-03-14
LATEST ACTION
1978-03-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ACETAMINOPHEN AND CODEINE PHOSPHATEDiscontinued
ACETAMINOPHEN 300MG, CODEINE PHOSPHATE 30MG · TABLET · ORAL
Approval history
1978-03-14OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.